Delivery Order SPE2DB20D2014-SPE2DB25FB64D

Award Date 4/15/25
Potential Completion Date 4/16/25
Potential Value $4.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $27,416.59 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Rebif 22 mcg/0.5 mL syringes, with a performance period ending on May 9, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $35,268.40 delivery order contract is for the supply of Rebif 44 mcg/0.5 mL syringes, a multiple sclerosis medication. The contract is a firm fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is for $11,892.98 to provide Rebif 44 mcg/0.5 mL syringes to support military treatment programs and facilities. The delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a...
This firm-fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $53,763.62 contract is for the supply of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a specialty medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,540.37, is for the delivery of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. This is a delivery order contract, with a firm fixed-price pricing type, and an ultimate completion date of December 18, 2024. The contract does not have a set-aside designation, indicating open...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML. The firm-fixed-price contract has a ceiling value of $14,678.72 and a period of performance through May 7, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $16,070.04 firm fixed-price award is for the supply of Rebif 44 mcg/0.5 ml syringes, a specialty medication, with a performance period through April 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a wide range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, at a ceiling value of $10,592.90. The contract is a Firm Fixed Price Delivery Order, with a period of performance through March 11, 2025. This contract award is not designated as a set-aside. AmerisourceBergen Drug Corp holds...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,442.94, is for the supply of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a specialty medication. The contract is a firm fixed-price delivery order with a period of performance through July 17, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Rebif Rebidose 44 mcg/0.5 ml prescription medication. The contract has a ceiling value of $6,200.73 and a performance period through December 19, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB64D
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Rebif 44 mcg/0.5 mL syringes, a prescription medication used to treat relapsing forms of multiple sclerosis. The contract has a firm fixed price of $4,328.37 and a period of performance through April 16, 2025. This order is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 7/15/25, 3:57 PM